Cornell
UCalgary, Cornell Get $2.4M DoD Grant for Trial of Syantra Breast Cancer Test
The liquid biopsy test was developed in the lab of University of Calgary researcher Kristina Rinker, who cofounded a company to commercialize it.
Cornell University Licenses UBR5 Inhibitor Program to Bridge Medicines
The New York-based drugmaker will further develop the anti-UBR5 molecules for treatment-resistant TNBC and ovarian cancers